RXO Q2 Adj EPS $0.08 Beats $0.07 Estimate, Sales $963.00M Miss $1.00B Estimate
Portfolio Pulse from Benzinga Newsdesk
RXO reported Q2 earnings of $0.08 per share, beating the analyst consensus estimate of $0.07 by 14.29%. However, the company's quarterly sales of $963.00 million missed the analyst consensus estimate of $1.00 billion by 3.70%. This represents a 85.71% decrease in earnings and a 21.45% decrease in sales compared to the same period last year.
August 04, 2023 | 10:50 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RXO's Q2 earnings beat estimates but sales missed, with significant YoY decreases in both earnings and sales. This mixed result could lead to uncertainty in the market.
RXO's earnings beat could be seen as a positive sign by investors, potentially driving the stock price up. However, the miss on sales and the significant year-over-year decreases in both earnings and sales could be seen as negative, potentially driving the stock price down. The net effect on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100